The first review study on association of DNA methylation with gastric cancer in Iranian population

  • Shahbazi, Mahsa (School of Veterinary Medicine, Razi University) ;
  • Yari, Kheirollah (Student Research Committee, Medical Biology Research Center, Kermanshah University of Medical Sciences) ;
  • Rezania, Niloufar (Department of Microbiology, Islamic Azad University of Varamin)
  • Published : 2016.05.01


Background: Gastric cancer (GC) is the second leading cause of cancer-related death worldwide. Several environmental, genetic and epigenetic factors have been suggested to have a role in GC development. Epigenetic mechanisms like histone changes and promoter hyper-methylation are now being increasingly studied. Associations between methylation of many gene promoters with the risk of gastric cancer have been investigated worldwide. Such aberrant methylation may result in silencing of specific genes related to cell cycling, cell adhesion, apoptosis and DNA repair. Thus this molecular mechanism might have a key role in proliferation and migration of cancerous cells. Materials and Methods: In this review article we included studies conducted on DNA methylation and gastric cancer in Iranian populations. Using Science direct, Pubmed/PMC, Springer, Wiley online library and SciELO databases, all published data until 31 January 2016 were gathered. We also searched Science direct data base for similar investigations around the world to make a comparison between Iran and other countries. Results: By searching these databases, we found that the association between methylation of seven gene promoters and gastric cancer had been studied in Iran until 31 January 2016. These genes were p16, hLMH1, E-cadherin, CTLA4, $THR{\beta}$, mir9 and APC. Searching in science direct database also showed that 92 articles had been published around the world till January 2016. Our investigation revealed that despite the importance of GC and its high prevalence in Iran, the methylation status of only a few gene promoters has been studied so far. More studies with higher sample numbers are needed to reveal the relation of methylation status of gene promoters to gastric cancer in Iran. Conclusions: Further studies will be helpful in identifying associations of DNA methylation in candidate genes with gastric cancer risk in Iranian populations.


Methylation;epigenetic mechansims;gastric cancer;Iran


  1. Abbaszadegan MR, Moaven O, Sima HR, et al (2008). p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol, 14, 2055.
  2. Alireza S, Mehdi N, Ali M, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359.
  3. Alivand MR, Jazii FR, Banoei MM, et al APC methylation status in Gastric Adenocarcinoma among Iranian: Semi-qualified marker for early event in carcinogenesis.
  4. Aranda A, Martinez-Iglesias O, Ruiz-Llorente L, et al (2009). Thyroid receptor: roles in cancer. Trends Endocrinol Metab, 20, 318-24.
  5. Bandres E, Agirre X, Bitarte N, et al (2009). Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer, 125, 2737-43.
  6. Bird A (2002). DNA methylation patterns and epigenetic memory. Genes Development, 16, 6-21.
  7. Buffart TE, Carvalho B, Hopmans E, et al (2007). Gastric cancers in young and elderly patients show different genomic profiles. J Pathol, 211, 45-51.
  8. Cheng ZD, Hu SL, Sun YB, et al (2010). Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods. Chin J Cancer, 29, 163-6.
  9. Ebrahimi-Askari R, Behmanesh M, Soleimani M (2015). Analyses of methylation status of CpG islands in promoters of miR-9 genes family in human gastric adenocarcinoma. Molecular Biology Res Communications, 4, 73-82.
  10. Erfani N, Mehrabadi SM, Ghayumi MA, et al (2012). Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung Cancer, 77, 306-11.
  11. Falsafi T, Valizadeh N, Sepehr S, et al (2005). Application of a stool antigen test to evaluate the incidence of Helicobacter pylori infection in children and adolescents from Tehran, Iran. Clinical Diagnostic Laboratory Immunol, 12, 1094-7.
  12. Fleisher AS, Esteller M, Tamura G, et al (2001). Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene, 20, 329-35.
  13. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
  14. Honda T, Tamura G, Waki T, et al (2004). Promoter hypermethylation of the Chfr gene in neoplastic and nonneoplastic gastric epithelia. British J Cancer, 90, 2013-6.
  15. Jones PL, Veenstra GCJ, Wade PA, et al (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genetics, 19, 187-91.
  16. Kang GH, Lee S, Kim J-S, et al (2003). Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Laboratory Investigation, 83, 635-41.
  17. Kawanishi K, Doki Y, Shiozaki H, et al (2000). Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers. American journal of clinical pathology, 113, 266-74.
  18. Kazemi E, Kahrizi D, Moradi M, et al (2015). Association between Helicobacter pylori hopQI genotypes and human gastric cancer risk. Cellular Molecular Biol, 62, 6-9.
  19. Kordi-Tamandani DM, Davani SK, Baranzehi T, et al (2014a). Analysis of promoter methylation, polymorphism and expression profile of cytotoxic t-lymphocyte-associated antigen-4 in patients with gastric cancer. J Gastrointestinal Liver Diseases, 23, 249-53.
  20. Kordi-Tamandani DM, Davani SK, Baranzehi T, et al (2014b). Analysis of promoter methylation, polymorphism and expression profile of cytotoxic T-lymphocyte-associated antigen-4 in patients with gastric cancer. J Gastrointestin Liver Dis, 23, 249-53.
  21. Lee J-H, Park S-J, Abraham SC, et al (2004). Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene, 23, 4646-54.
  22. Mansour-Ghanaei F, Mashhour MY, Joukar F, et al (2009). Prevalence of Helicobacter pylori infection among children in Rasht, Northern Iran. Middle East J Digestive Diseases, 1, 84-8.
  23. McNamara D, El-Omar E (2008). Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Digestive Liver Disease, 40, 504-9.
  24. Moghbeli M, Moaven O, Memar B, et al (2014). Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression. Journal of gastrointestinal cancer, 45, 40-7.
  25. Munoz N, Franceschi S (1997). Epidemiology of gastric cancer and perspectives for prevention. Salud publica de Mexico, 39, 318-30.
  26. Nan X, Ng H-H, Johnson CA, et al (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-9.
  27. Nouraie M, Latifi-Navid S, Rezvan H, et al (2009). Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter, 14, 40-6.
  28. Park JW, Zhao L, Cheng SY (2013). Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor beta in xenograft models. Am J Cancer Res, 3, 302-11.
  29. Pourfarzi F, Whelan A, Kaldor J, et al (2009). The role of diet and other environmental factors in the causation of gastric cancer in Iran-a population based study. International J Cancer, 125, 1953-60.
  30. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: Results of a population-based Cancer Registry from Iran. International J Cancer, 107, 113-8.
  31. Sato F, Meltzer SJ (2006). CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer, 106, 483-93.
  32. Sherr CJ (2000). The Pezcoller lecture: cancer cell cycles revisited. Cancer Res, 60, 3689-95.
  33. Sudo M, Chong JM, Sakuma K, et al (2004). Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. International J Cancer, 109, 194-9.
  34. Suzuki K, Suzuki I, Leodolter A, et al (2006). Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell, 9, 199-207.
  35. Tamandani DMK, Hemati S, Davani SK, et al (2015). Association between promoter methylation and expression of thyroid hormone receptor beta (THR beta) gene in patients with gastric cancer in an Iranian population. J Gastroenterol Hepatol, 30, 485-9.
  36. van Engeland M, Weijenberg MP, Roemen GM, et al (2003). Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer research, 63, 3133-7.
  37. Waki T, Tamura G, Sato M, et al (2003). Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene, 22, 4128-33.
  38. Xiao XQ, Gong WD, Wang SZ, et al (2012). Polymorphisms of mismatch repair gene hMLH1 and hMSH2 and risk of gastric cancer in a Chinese population. Oncol Lett, 3, 591-8.
  39. Yari K, Payandeh M, Rahimi Z (2015). Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran. Tumour Biol.
  40. Yu J, Ebert M, Miehlke S, et al (2000). ${\alpha}$-Catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut, 46, 639-44.
  41. Zhao YF, Zhang YG, Tian XX, et al (2007). Aberrant methylation of multiple genes in gastric carcinomas. Int J Surgical Pathol, 15, 242-51.